Regeneron Pharmaceuticals Current Assets

Regeneron Pharmaceuticals (0R2M.L) currently reports a current assets of $18K as of June 2026. That compares with $17B in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Regeneron Pharmaceuticals's current assets history and peer comparisons.

Regeneron Pharmaceuticals's current assets decreased from $17B to $18K — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Regeneron Pharmaceuticals reported $18K in current assets as of June 2026. That compares with $17B in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $18K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regeneron Pharmaceuticals, and consider following 0R2M.L for alerts when major investors trade the stock.

Regeneron Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $18K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0R2M.L with unrelated industries.